tirzepatide adolescent Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial Lilly's Mounjaro (tirzepatide), a GIP/GLP-1

Pratley R, Amod A, Hoff ST, Kadowaki T, Lingvay I, Nauck M et al (2019) Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial

At 5 mg/mL, that would be 15 units

However, the medication works best when taken consistently each week, as regular use keeps it at steady levels in your body and ensures you get the full effect on blood sugar control and weight management

2013;17(4):507-vii

This orientation potentially stabilizes the L3 region

Applying it before shampooing, or rinsing it off after application, dramatically reduces its efficacy